300482 万孚生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.42011.15411.00731.10520.481
总资产报酬率 ROA (%)1.9378.6908.07821.45813.849
投入资产回报率 ROIC (%)2.1439.7459.13925.31016.723

边际利润分析
销售毛利率 (%)60.29864.14562.61151.82458.463
营业利润率 (%)7.67620.77919.86124.07820.586
息税前利润/营业总收入 (%)9.17620.61119.32624.00921.702
净利润/营业总收入 (%)7.48118.44217.62920.95118.821

收益指标分析
经营活动净收益/利润总额(%)69.213100.22086.96398.97188.859
价值变动净收益/利润总额(%)30.6415.0108.4885.3198.526
营业外收支净额/利润总额(%)-2.467-1.173-1.549-0.235-1.677

偿债能力分析
流动比率 (X)7.7764.6096.6772.9363.266
速动比率 (X)6.9534.1715.9522.5862.778
资产负债率 (%)16.41521.02620.04827.98827.838
带息债务/全部投入资本 (%)9.9689.66611.76218.14415.825
股东权益/带息债务 (%)888.751916.117730.796441.986524.162
股东权益/负债合计 (%)503.690369.218390.286246.313248.056
利息保障倍数 (X)5.446284.607-83.428-1,954.01314.910

营运能力分析
应收账款周转天数 (天)172.615100.64874.11032.90741.111
存货周转天数 (天)142.044116.457130.82851.71398.364